Bengt Ullman
Karolinska Institutet
8 Papers
1 Citations
Bengt Ullman is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
Göran Rådegran,Barbro Kjellström,Björn Ekmehag,Flemming Larsen,Bengt Rundqvist,Sofia Berg Blomquist,Carola Gustafsson,Roger Hesselstrand,Monica Karlsson,Björn Kornhall,Magnus Nisell,Liselotte Persson,Henrik Ryftenius,Maria Selin,Bengt Ullman,Kent Wall,Gerhard Wikström,Maria Willehadson,Kjell Jansson,Spahr +19 more
TL;DR: The majority of the PAH and CTEPH patients were diagnosed at age >65 years, in functional class III–IV, and exhibiting several comorbidities, and PAH survival in SPAHR was similar to other registers.
Patient-centred home-based management of heart failure. Findings from a randomised clinical trial evaluating a tablet computer for self-care, quality of life and effects on knowledge.
Ewa Hägglund,Patrik Lyngå,Filippa Frie,Bengt Ullman,Hans Persson,Michael Melin,Inger Hagerman +6 more
TL;DR: HF patients with a HIS tablet computer and scale improved in self-care and HRQoL and days in hospital due to HF were reduced.
109
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
TL;DR: Infusion of exenatide in male type 2 diabetic patients with CHF increased the CI as a result of chronotropy, with concomitant favourable effects on PCWP and reasonable tolerability of the drug.
Effects of a Tablet Computer on Self-care, Quality of Life, and Knowledge: A Randomized Clinical Trial.
TL;DR: The tablet computer significantly improved self-care behavior and health related quality of life, increased HF knowledge, and reduced hospital days.
39
Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure
TL;DR: Exenatide infusion decreases cardiac filling pressure and ANP levels, and it seems unlikely that this was mediated via ANP, but a negative correlation betweenANP levels and PCWP, PAP, and RAP was demonstrated during exen atide infusion.